Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP803672.RA11OZ28Ntp7ydtXkqG1-UEDLmRh0jMm3iSJMUoNzIrJI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP803672.RA11OZ28Ntp7ydtXkqG1-UEDLmRh0jMm3iSJMUoNzIrJI130_assertion type Assertion NP803672.RA11OZ28Ntp7ydtXkqG1-UEDLmRh0jMm3iSJMUoNzIrJI130_head.
- NP803672.RA11OZ28Ntp7ydtXkqG1-UEDLmRh0jMm3iSJMUoNzIrJI130_assertion description "[KRAS is frequently mutated in nonsmall cell lung cancer (NSCLC), resulting in the activation of the MAPK/ERK kinase (MEK)/ERK pathway.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP803672.RA11OZ28Ntp7ydtXkqG1-UEDLmRh0jMm3iSJMUoNzIrJI130_provenance.
- NP803672.RA11OZ28Ntp7ydtXkqG1-UEDLmRh0jMm3iSJMUoNzIrJI130_assertion evidence source_evidence_literature NP803672.RA11OZ28Ntp7ydtXkqG1-UEDLmRh0jMm3iSJMUoNzIrJI130_provenance.
- NP803672.RA11OZ28Ntp7ydtXkqG1-UEDLmRh0jMm3iSJMUoNzIrJI130_assertion SIO_000772 20358631 NP803672.RA11OZ28Ntp7ydtXkqG1-UEDLmRh0jMm3iSJMUoNzIrJI130_provenance.
- NP803672.RA11OZ28Ntp7ydtXkqG1-UEDLmRh0jMm3iSJMUoNzIrJI130_assertion wasDerivedFrom befree-2016 NP803672.RA11OZ28Ntp7ydtXkqG1-UEDLmRh0jMm3iSJMUoNzIrJI130_provenance.
- NP803672.RA11OZ28Ntp7ydtXkqG1-UEDLmRh0jMm3iSJMUoNzIrJI130_assertion wasGeneratedBy ECO_0000203 NP803672.RA11OZ28Ntp7ydtXkqG1-UEDLmRh0jMm3iSJMUoNzIrJI130_provenance.